StonvexLoading…
StonvexCore line items from AVD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $123.57M | $515.11M | $364.43M | $245.11M |
Operating Income | $1.89M | $-28.30M | $-6.45M | $56.00K |
Net Income | $-4.14M | $-49.88M | $-21.67M | $-9.31M |
EPS (Diluted) | $-0.14 | $-1.75 | $-0.76 | $-0.33 |
Total Assets | $665.24M | $596.54M | $655.01M | $651.98M |
Total Liabilities | $475.62M | $404.14M | $434.02M | $421.16M |
Cash & Equivalents | $70.91M | $12.43M | $16.80M | $14.48M |
Free Cash Flow OCF − CapEx | $-36.41M | $-25.11M | $-29.54M | $-40.86M |
Shares Outstanding | 28.65M | 28.43M | 28.38M | 28.31M |